Dengue, dengue hemorrhagic fever

International Encyclopedia of Public Health

Volumn , Issue , 2008, Pages 98-119

  Guzman, M G ^a   Perez, A B ^a   Fuentes, O ^a   Kouri, G ^a  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

Author keywords

Aedas albopictus; Aedes aegypti; Arbovirus; Arthropod borne virus; Dengue; Dengue hermorrhagic fever; Flavivirus; Genotypes; Immunoenhancement; Pathogenesis; Vector borne disease; Viral hemorrhagic fever

Indexed keywords

EID: 84883576556     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012373960-5.00564-5     Document Type: Chapter

References (31)

1. Bandyopadhyay S., Lum L.C.S., Kroeger A. Classifying dengue: A review of the difficulties in using the WHO case classification for dengue haemorrhagic fever. Tropical Medicine International Health 2006, 11:1238-1255.
2. Dengue fever. CDC Health Information for International Travel 2008, ch.4 2007, CDC, US Department of Health and Human Services, Public Health Service, Atlanta, GA, (accessed October 2007). http://wwwn.cdc.gov/travel/yellowbookch4-DengueFever.aspx, P.M. Arguin, P.E. Kozarsky, C. Reed (Eds.).
3. Christophers S.R. Aedes aegypti L. The Yellow Fever Mosquito: Its Life History, Bionomics and Structure 1960, Cambridge University Press, Cambridge, UK.
4. Dengue and Dengue Hemorrhagic Fever 1997, CAB International, Wallington, UK. D.J. Gubler, G. Kuno (Eds.).
5. Guzman M.G., Kouri G., Valdes L., Bravo J., Vazquez S., Halstead S.B. Enhanced severity of secondary dengue-2 infections: Death rates in 1981 and 1997 Cuban outbreaks. Pan American Journal of Public Health 2002, 11:223-227.
6. Halstead S.B., Heinz F.X., Barret A.D.T., Roehrig J.T. Dengue virus: Molecular basis of cell entry and pathogenesis, 25-27 June 2003, Vienna, Austria. Vaccine 2005, 23:849-856.
7. Holmes E.C., Burch S.S. The causes and consequences of genetic variation in dengue virus. Trends in Microbiology 2000, 8:74-77.
8. Holmes E.C., Twiddy S.S. The origin, emergence and evolutionary genetics of dengue virus. Infection, Genetics and Evolution 2003, 3:19-28.
9. Hombach J., Barret A.D., Cardosa M.J., et al. Review on flavivirus vaccine development. Proceedings of a meeting jointly organized by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, Thailand. Vaccine 2005, 23:2689-2695.
10. Kay B. Dengue vector surveillance and control. Current Opinion in Infectious Diseases 1999, 12:425-432.
11. Kouri G., Guzman M.G., Bravo J.R., Triana C. Dengue hemorrhagic fever/dengue shock syndrome: Lessons from the Cuban epidemic, 1981. Bulletin of the World Health Organization 1989, 67:375-380.
12. Kuhn R.J., Zhang W., Rossman M.G., et al. Structure of dengue virus: Implications for flavivirus organization, maturation and fusion. Cell 2002, 108:717-725.
13. Mongkolsalpaya J., Dejnirattisai W., Xu N., et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nature Medicine 2003, 9:921-927.
14. Navarro-Sanchez E., Despres P., Cedillo-Barron L. Innate immunity in dengue. Archives of Medical Research 2005, 36:425-435.
15. Pang T. Vaccines for the prevention of neglected diseases: Dengue fever. Current Opinion in Biotechnology 2003, 14:332-336.
16. Raviprakash K., Apt D., Brinkman A., et al. A chimeric tetravalent DNA vaccine elicits neutralizing antibody to all four virus serotypes in rhesus macaques. Virology 2006, 353:166-173.
17. Sierra B., Kourí G., Guzman M.G. Race: A risk factor for dengue hemorrhagic fever. Archives of Virology 2006, 152:533-542.
18. Chatuverdi U.C., Nagar R., Shrivastava R. Dengue and dengue haemorrhagic fever: Implications of host genetic. FEMS Immunology and Medicine Microbiology 2006, 47:155-166.
19. Fink J., Gu F., Vasudevan S. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever. Review in Medical Virology 2006, 16:263-275.
20. Gratz N.G., Knudsen A.B. The Rise and Spread of Dengue, Dengue Hemorrhagic Fever and Its Vectors: A Historical Review (up to 1995) 1995, World Health Organization CTD/FIL(DEN) 96.7.
21. Green S., Rothman A. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Current Opinion in Infectious Diseases 2006, 19:429-436.
22. Guzman M.G., Kouri G. Dengue: An update. Lancet Infectious Disease 2002, 2:33-42.
23. Guzman M.G., Kouri G. Dengue diagnosis, advances and challenges. International Journal of Infectious Diseases 2004, 8:69-80.
24. Halstead S.B. Neutralization and antibody-dependent enhancement of dengue viruses. Advances in Virus Research 2003, 60:421-467.
25. Molecular Biology of the Flavivirus 2006, Horizon Bioscience, Norwich, UK. M. Kalitzky, P. Borowski (Eds.).
26. Communicable Diseases, 2002: Global Defense Against the Infectious Disease Threat 2003, World Health Organization, Geneva, Switzerland. M.K. Kindhauser (Ed.).
27. Rico-Hesse R. Microevolution and virulence of dengue viruses. Advances in Virus Research 2003, 59:315-341.
28. Meeting report. Report of the Scientific Working Group on Dengue 2000, TDR/WHO, WHO, Geneva, Switzerland, TDR/DEN/SWG/00.1.
29. Thongcharoen P. Monograph on Dengue/Dengue Haemorrhagic Fever 1993, WHO Regional Office for Southeast Asia, New Delhi, Regional Publication, SEARO No. 22.
30. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control 1997, WHO, World Health Organization, Geneva, Switzerland. 2nd edn.
31. Dengue Diagnostics: Proceedings of an International Workshop 2004, WHO/TDR, Geneva, Switzerland, 4-6 October.